Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) Short Interest Update

Laboratorios Farmaceuticos Rovi, S.A. (OTCMKTS:LABFF) was the target of a large increase in short interest in the month of October. As of October 15th, there was short interest totalling 5,800 shares, an increase of 100.0% from the September 30th total of 2,900 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Laboratorios Farmaceuticos Rovi Price Performance

LABFF stock remained flat at C$90.61 during trading on Monday. Laboratorios Farmaceuticos Rovi has a 52-week low of C$90.61 and a 52-week high of C$90.61. The stock has a 50 day moving average of C$90.61 and a 200 day moving average of C$88.75.

About Laboratorios Farmaceuticos Rovi

Laboratorios Farmaceuticos Rovi, SA engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas.